An Ongoing Phase 2a Study To Investigate Drug-Drug Interactions Between Escalating Doses of At2220 (Duvoglustat Hydrochloride) and Acid Alpha Glucosidase in Subjects With Pompe Disease - Preliminary Results Academic Article
Identity
Web of Science ID
- 000310103600153
Digital Object Identifier (DOI)
Additional Document Info
start page
- 852
volume
- 22